Kupelian PA - Search Results

1

Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.

Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G. Paris PL, et al. Among authors: kupelian pa. Cancer Res. 2000 Jul 1;60(13):3645-9. Cancer Res. 2000. PMID: 10910080

2

Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.

Paris PL, Kupelian PA, Hall JM, Williams TL, Levin H, Klein EA, Casey G, Witte JS. Paris PL, et al. Among authors: kupelian pa. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):901-5. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10548319

3

Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.

Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA. Kupelian PA, et al. Cancer. 2002 Dec 1;95(11):2302-7. doi: 10.1002/cncr.10977. Cancer. 2002. PMID: 12436435 Free article.

4

Localized prostate cancer: radiation or surgery?

Klein EA, Kupelian PA. Klein EA, et al. Among authors: kupelian pa. Urol Clin North Am. 2003 May;30(2):315-30, ix. doi: 10.1016/s0094-0143(02)00179-9. Urol Clin North Am. 2003. PMID: 12735507 Review.

5

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA. Khuntia D, et al. Among authors: kupelian pa. Cancer. 2004 Mar 15;100(6):1283-92. doi: 10.1002/cncr.20093. Cancer. 2004. PMID: 15022298 Free article.

6

Aggressiveness of familial prostate cancer.

Kupelian PA, Reddy CA, Reuther AM, Mahadevan A, Ciezki JP, Klein EA. Kupelian PA, et al. J Clin Oncol. 2006 Jul 20;24(21):3445-50. doi: 10.1200/JCO.2006.05.7661. J Clin Oncol. 2006. PMID: 16849760

7

External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.

Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E. Kupelian P, et al. Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87. Cancer J Sci Am. 1997. PMID: 9099457

8

Locally advanced prostate cancer.

Klein EA, Kupelian PA, Dreicer R, Peereboom D, Zippe C. Klein EA, et al. Among authors: kupelian pa. Curr Treat Options Oncol. 2001 Oct;2(5):403-11. doi: 10.1007/s11864-001-0045-1. Curr Treat Options Oncol. 2001. PMID: 12057103 Review.

9

Localized prostate cancer.

Klein EA, Kupelian PA. Klein EA, et al. Among authors: kupelian pa. Curr Treat Options Oncol. 2000 Dec;1(5):433-45. doi: 10.1007/s11864-000-0071-4. Curr Treat Options Oncol. 2000. PMID: 12057151 Review.

10

Does a family history of prostate cancer result in more aggressive disease?

Klein EA, Kupelian PA, Witte JS. Klein EA, et al. Among authors: kupelian pa. Prostate Cancer Prostatic Dis. 1998 Dec;1(6):297-300. doi: 10.1038/sj.pcan.4500257. Prostate Cancer Prostatic Dis. 1998. PMID: 12496870 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page